Daily Med News

Lung Cancer Remains At Bay Long After Immune Therapy Is Dropped

MONDAY, April 21, 2025 — Immunotherapy might help keep lung cancer at bay for months or even years after the treatment has been abandoned due to side effects, a new study says.
Immune checkpoint inhibitors essentially take the brakes off the…

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]